← FDA DRUG APPROVALS

FDA ANDA · ANDA212402

METOPROLOL TARTRATE

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA212402
TYPE
ANDA
ORIGINAL APPROVAL
2023-04-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 100MG · TABLET · ORAL
METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 25MG · TABLET · ORAL
METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 50MG · TABLET · ORAL

Approval history

2024-11-21Labeling · Supplement 2 · standardAP
2023-12-27Labeling · Supplement 1 · standardAP
2023-04-19UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →